U.S. Companion Animal Diagnostics Market Size Predicted to Hit USD 3,271.71 million by 2032 at 8.2% CAGR, Says AMR

Allied Market Research published a report, titled, "U.S. Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Immunodiagnostics, Hematology, Molecular Diagnostics, Urinalysis, and Others), Applications (Clinical Pathology, Bacteriology, Virology, Parasitology, and Others), Animal Type (Dogs, Cats, and Others), End User (Diagnostics Labs, Point of Care and In-House Testing, Research Institutes and Universities, and Veterinary Hospitals and Clinics) Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the U.S. companion animal diagnostics market was valued at USD 1,491.11 million in 2022 and is projected to reach USD 3,271.71 million by 2032, registering a CAGR of 8.2% from 2023 to 2032.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨

• The outbreak of the Covid-19 pandemic had negatively impacted the U.S. companion animal diagnostic market.
• The travel restrictions imposed during the lockdown has disrupted the supply chain for the companion animal diagnostic products.
• However, market for companion animal diagnostics is expected to recover owing to rise in awareness about animal healthcare among the pet owners and surge in pet adoption in U.S.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐟 𝐔.𝐒. 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐨𝐧 𝐀𝐧𝐢𝐦𝐚𝐥 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

• Alfa Wassermann, Inc.
• AnimalBiome
• Biomerieux SA
• BioNote Inc.
• Bio-Rad Laboratories
• Creative Diagnostics
• Fujifilm Holdings Corporation
• Heska Corporation
• Idexx Laboratories Inc
• Indical Bioscience GmbH
• Innovative Diagnostics
• Neogen Corporation,
• Randox Laboratories Ltd.
• Shenzhen Mindray Animal Medical Technology Co. Ltd
• Thermo Fisher Scientific
• Virbac
• Zoetis Inc.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/A22544

𝐏𝐫𝐢𝐦𝐞 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐠𝐫𝐨𝐰𝐭𝐡

The U.S. companion animal diagnostic market has experienced significant growth due to a surge in pet ownership in U.S. This surge in pet ownership, driven by factors such as evolving societal dynamics and increased understanding of the emotional and health benefits of pet companionship, has led to a substantial increase in the demand for advanced diagnostic services tailored to detect, monitor, and manage the growing spectrum of chronic diseases affecting companion animals. Furthermore, technological advancement in pet diagnosis and rise in number of insured pets is expected to significantly contribute in market growth.

The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.
The clinical biochemistry segment to maintain its leadership status throughout the forecast period

Based on technology, the clinical biochemistry segment held the highest market share in 2022, accounting for one third of the U.S. companion animal diagnostic market revenue, owing to the ability of clinical biochemistry technology to test for wide array of diseases in companion animals.

The clinical pathology segment to maintain its leadership status throughout the forecast period

Based on applications, the clinical pathology segment held the highest market share in 2022, accounting for more than one third of the U.S. companion animal diagnostic market revenue. This is attributed to the rise in incidence of chronic diseases such as diabetes, cancer and other.

The dog segment to maintain its leadership status throughout the forecast period

Based on animal type, the dog segment held the highest market share in 2022, accounting for nearly half of the U.S. companion animal diagnostic market revenue. This is attributed to high adoption of dogs at companion animal in U.S.

The diagnostics labs segment to maintain its leadership status throughout the forecast period

Based on end user, the diagnostics labs segment held the highest market share in 2022, accounting for more than one third of the U.S. companion animal diagnostic market revenue. This is attributed to high adoption of diagnostic products in the diagnostic labs for detection of diseases in companion animals.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/A22544

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America

(U.S., Canada, Mexico)

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.